Back to Companies
RHYTHM PHARMACEUTICALS, INC.
RYTMNasdaqCIK: 0001649904
Recent Form 4 activity at RHYTHM PHARMACEUTICALS, INC. (RYTM) spans 46 filings across 16 insiders (all of them on the sell side). Purchases total $0 against $34.0M in sales — heavily weighted toward selling, for net sales of $34.0M. Lee Jennifer Kayden (EVP, Head of North America) is the most active by dollar volume, and the single largest transaction was $10.9M by Lee Jennifer Kayden. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$83.2M
Purchases
$0
Sales
$34.0M
Unique Insiders
16
Recent Insider Trades
46 loaded
| Aug 18 | RYTM RHYTHM PHARMACEUTICALS, INC. | Joshi Manher | Chief Medical Officer | Other | $0 |
| Aug 18 | RYTM RHYTHM PHARMACEUTICALS, INC. | Joshi Manher | Chief Medical Officer | Award | $5.8M |
| Aug 14 | RYTM RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | Sell | $8.9M |
| Aug 17 | RYTM RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Chief Scientific Officer | Sell | $912.7K |
| Aug 17 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Sell | $608.2K |
| Aug 14 | RYTM RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | Sell | $6.6M |
| Jul 2 | RYTM RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Chief Scientific Officer | Exercise | $237.4K |
| Jun 25 | RYTM RHYTHM PHARMACEUTICALS, INC. | TETRAULT LYNN A. | Director | Exercise | $397.0K |
| Jun 25 | RYTM RHYTHM PHARMACEUTICALS, INC. | JEAN CHRISTOPHE | Director | Exercise | $397.0K |
| Jun 25 | RYTM RHYTHM PHARMACEUTICALS, INC. | GOOD JENNIFER L | Director | Exercise | $397.0K |
| Jun 25 | RYTM RHYTHM PHARMACEUTICALS, INC. | MCGIRR DAVID W J | Director | Exercise | $397.0K |
| Jun 25 | RYTM RHYTHM PHARMACEUTICALS, INC. | Arbuckle Stuart A | Director | Exercise | $397.0K |
| Jun 24 | RYTM RHYTHM PHARMACEUTICALS, INC. | TETRAULT LYNN A. | Director | Sell | $3.7M |
| Apr 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | Popovits Kimberly J | Director | Award | $903.8K |
| Apr 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | Popovits Kimberly J | Director | Other | $0 |
| Apr 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | Exercise | $0 |
| Mar 16 | RYTM RHYTHM PHARMACEUTICALS, INC. | Mathers Edward T | Insider | Other | $0 |
| Mar 6 | RYTM RHYTHM PHARMACEUTICALS, INC. | German Christopher Paul | Corporate Controller & CAO | Sell | $502.8K |
| Mar 2 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Exercise | $82.9K |
| Mar 4 | RYTM RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | Award | $3.3M |
| Mar 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | German Christopher Paul | Corporate Controller & CAO | Exercise | $32.5K |
| Feb 19 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $805.8K |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Mazabraud Yann | EVP, Head of International | Award | $0 |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | Award | $3.2M |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Award | $2.2M |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Meeker David P | President and CEO, Director | Award | $10.6M |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | German Christopher Paul | Corporate Controller & CAO | Award | $0 |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Garfield Alastair | Chief Scientific Officer | Award | $2.5M |
| Feb 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | Chief Human Resources Officer | Award | $1.7M |
| Feb 12 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $708.6K |
| Feb 6 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $702.7K |
| Feb 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | Lee Jennifer Kayden | EVP, Head of North America | Exercise | $1.0M |
| Feb 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | Meeker David P | President and CEO, Director | Exercise | $3.4M |
| Feb 3 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Exercise | $709.2K |
| Nov 24 | RYTM RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | Chief Human Resources Officer | Sell | $351.8K |
| Oct 30 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Sell | $323.8K |
| Sep 4 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Sell | $1.8M |
| Aug 25 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Sell | $419.1K |
| Aug 14 | RYTM RHYTHM PHARMACEUTICALS, INC. | German Christopher Paul | Corporate Controller & CAO | Sell | $142.5K |
| Aug 14 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $2.7M |
| Aug 13 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Sell | $358.9K |
| Jul 29 | RYTM RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | Chief Human Resources Officer | Sell | $130.6K |
| Jul 11 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Sell | $3.4M |
| Jul 11 | RYTM RHYTHM PHARMACEUTICALS, INC. | German Christopher Paul | Corporate Controller & CAO | Sell | $308.2K |
| Jul 11 | RYTM RHYTHM PHARMACEUTICALS, INC. | Shulman Joseph | Chief Technical Officer | Sell | $619.9K |
| Jul 8 | RYTM RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Chief Financial Officer | Exercise | $96.1K |
46 filings